A PROSPECTIVE PHASE III RANDOMIZED TRIAL OF HYPOFRACTIONATION VERSUS CONVENTIONAL FRACTIONATION IN PATIENTS WITH HIGH-RISK PROSTATE CANCER

被引：0
|
作者：
Arcangeli, G. [1 ]
Arcangeli, S. [2 ]
Saracino, B. M. [1 ]
Petrongari, M. G. [1 ]
Gomellini, S. [1 ]
Strigari, L. [3 ]
Fowler, J. [4 ]
机构：
[1] Regina Elena Inst Canc Res, Radioterapia, Rome, Italy
[2] Regina Elena Inst Canc Res, Radioterapia, Rome, Italy
[3] Regina Elena Inst Canc Res, Lab Med Phys & Expert Syst, Rome, Italy
[4] Univ Wisconsin, Human Oncol & Med Phys, Madison, WI USA
来源：
RADIOTHERAPY AND ONCOLOGY | 2010年 / 96卷
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
390
引用
收藏
页码：S147 / S147
页数：1
相关论文
共 50 条
  • [21] Acute toxicity and quality of life in high risk prostate cancer patients: Updated results of randomized hypofractionation trial
    Karklelyte, Agata
    Valuckas, Konstantinas Povilas
    Griskevicius, Romas
    Janulionis, Ernestas
    Aleknavicius, Eduardas
    REPORTS OF PRACTICAL ONCOLOGY AND RADIOTHERAPY, 2018, 23 (04) : 284 - 289
  • [22] Prostate-Only Versus Whole-Pelvic Radiation Therapy in High-Risk and Very High-Risk Prostate Cancer (POP-RT): Outcomes From Phase III Randomized Controlled Trial
    Murthy, Vedang
    Maitre, Priyamvada
    Kannan, Sadhana
    Panigrahi, Gitanjali
    Krishnatry, Rahul
    Bakshi, Ganesh
    Prakash, Gagan
    Pal, Mahendra
    Menon, Santosh
    Phurailatpam, Reena
    Mokal, Smruti
    Chaurasiya, Dipika
    Popat, Palak
    Sable, Nilesh
    Agarwal, Archi
    Rangarajan, Venkatesh
    Joshi, Amit
    Noronha, Vanita
    Prabhash, Kumar
    Mahantshetty, Umesh
    JOURNAL OF CLINICAL ONCOLOGY, 2021, 39 (11) : 1234 - +
  • [23] Conventional Versus Hypofractionated Radiation for High-Risk Prostate Cancer Patients (CHIRP): 24-Month Patient-Reported Outcomes of the Randomized Phase 2 CHIRP Trial
    Yang, Fan
    Ghosh, Sunita
    Yee, Don
    Patel, Samir
    Pervez, Nadeem
    Parliament, Matthew
    Usmani, Nawaid
    Danielson, Brita
    Amanie, John
    Pearcey, Robert
    Field, Colin
    Fallone, Gino
    Murtha, Albert
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2022, 114 (01): : 99 - 107
  • [24] Combined Risk Factors and Outcomes in High-Risk Prostate Cancer: Secondary Analysis of a Phase III Trial
    Nabid, A.
    Carrier, N.
    Bahoric, B.
    Wilke, D. R.
    Vigneault, E.
    Vincent, F.
    Brassard, M. A.
    Vavassis, P.
    Bettahar, R.
    Archambault, R.
    Nguyen, T. V.
    Martin, A. G.
    Bahary, J. P.
    Duclos, M.
    Vass, S. T., Jr.
    Souhami, L.
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2022, 114 (03): : E233 - E234
  • [25] Moderate Hypofractionation in Intermediate- and High-Risk, Localized Prostate Cancer: Health-Related Quality of Life From the Randomized, Phase 3 HYPRO Trial
    Wortel, Ruud C.
    Oomen-de Hoop, Esther
    Heemsbergen, Wilma D.
    Pos, Floris J.
    Incrocci, Luca
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2019, 103 (04): : 823 - 833
  • [26] Hypofractionated versus conventional radiotherapy in intermediate- to high-risk prostate cancer
    Guo, W.
    Gao, X. S.
    Gu, X. B.
    Ma, M. W.
    RADIOTHERAPY AND ONCOLOGY, 2017, 123 : S716 - S716
  • [27] Treatment-related Side Effects And Quality Of Life Among Prostate Cancer Patients Treated With Conventional versus Hypofractionated Intensity Mediated Radiotherapy: A Phase III Hypofractionation Trial
    Jean-Pierre, P.
    Stoyanova, R.
    Penedo, F.
    Antoni, M.
    Abramowitz, M.
    Buyyounouski, M.
    Pollack, A.
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2011, 81 (02): : S667 - S667
  • [28] STEREOTACTIC BODY VERSUS CONVENTIONAL FRACTIONATION EXTERNAL BEAM RADIOTHERAPY (EBRT) BOOST FOR HIGH-RISK PROSTATE CANCER (HR-PC); EARLY RESULTS OF PBS: A PHASE II RANDOMIZED TRIAL (NCT03380806)
    Gouveia, Andre
    Mesci, Aruz
    Isfahanian, Naghmeh
    Dayes, Ian
    Schnarr, Kara Lynne
    Quan, Kimmen
    Maharaj, Lindsay
    Cuthbert, David
    Hallock, Abhiram
    Douvi, Georgia
    Lukka, Himu
    Goldberg, Mira
    Wright, Jim
    Swaminath, Anand
    Chow, Tom
    Diamond, Kevin
    Ewusie, Joycelyne
    Hajdok, George
    Tsakiridis, Theodoros
    RADIOTHERAPY AND ONCOLOGY, 2024, 198 : S13 - S14
  • [29] A randomized phase III, factorial design, of cabazitaxel and pelvic radiotherapy in patients with localized prostate cancer and high-risk features of relapse
    Fizazi, Karim
    Habibian, Muriel
    Laplanche, Agnes
    Baumert, Herve
    Valdagni, Riccardo
    Carles, Joan
    Blanchard, Pierre
    JOURNAL OF CLINICAL ONCOLOGY, 2014, 32 (15)
  • [30] Prostate cancer and hypofractionation: reflections on recent randomised phase III clinical trial results
    Dearnaley, David
    Hall, Emma
    TRANSLATIONAL ANDROLOGY AND UROLOGY, 2017, 6 (01) : 134 - 136
12345